Cardium Therapeutics (NYSE Amex: CXM) has announced that its MedPodium Nutra-Apps® products will now be offered by USA Sports.
The MedPodium line features a pharmaceutical-type design that resonates with younger consumers, with easy-to-use dietary supplements that have been developed with young professionals in mind. Nutritional Products International (NPI), a Florida-based nutraceutical firm, is responsible for distributing the brand.
Included in the MedPodium line are the Nutra-Apps’ Neo-Carb Bloc® for weight management and Neo-Energy® for enhanced performance, both available in small, sealed and convenient packaging that allows them to fit into any purse or pocket. All of the products in the line feature scientifically validated ingredients at the clinically studied amounts for efficacy, providing added peace of mind for consumers.
USA Sports offers top-quality supplements and nutritional products to performance stores, convenience stores, gyms, health clubs, health food stores and web retail websites across the country. The company works with over 2,000 products from more than 100 brands, regularly adding to its extensive portfolio.
“The young professionals segment is a fast-growing market, and MedPodium is reaching out to these individuals with supplements that are created just for them,” said Brian Gould, Director of Operations for NPI. “The Nutra-Apps line has a tremendous amount of potential to achieve great things in the marketplace in the years to come.”
Read the complete press and get a Cardium Therapeutics stock quote at the link provided.
Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated two thousand five hundred dollars by Cardium Therapeutics for its efforts in managing the dissemination of public corporate information on its website and to its database of subscribers and across select financial and social media websites. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.